NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/01/2025
Back to search
Official data from USPTO
NORTHERA (DROXIDOPA) CAPSULES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
07/01/2025
Trademark type
Combined
Nice classes
36, 41, 44
Filing date
07/02/2024
Registration date
07/01/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/01/2025
Last transaction
07/01/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
08/20/2014
First use in commerce
08/20/2014
Drawing code
3
Owner type
03
Owner location
Deerfield, IL, US
Examiner
POLLACK, ALISON FRIEDBERG
Law office
L60
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized wording "Northera" in white lettering on one line and "(droxidopa) capsules" in white lettering on another line below it. In the upper right are five slightly overlapping stylized figures of a person fading from left to right in white to light blue to blue to slate gray in an arc each comprised of a shaded circle and curved triangle designs. The blue background is used for contrast with the white lettering and is not a feature of the mark.
Holders and representatives
Holders
Lundbeck NA Ltd.
Representatives
Maren C. Perry King & Spalding LLP
Technical classification
Nice Classes
Class 36Class 41Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 36
Providing insurance and insurance reimbursement information; financial administration of patient reimbursement programscopay financial assistance programs; providing patient support servicesproviding insurance information to help patients understand their insurance and plan benefitsproviding insurance information on insurance authorization formsappeals and statusproviding information on insurance-approved site-of-care facilitiesproviding insurance reimbursement assistance to eligible patients in the nature of reimbursement payment processing in the field of health and pharmaceutical insurance claims
Class 41
Providing a website via a global computer network featuring onlinenon-downloadable imagesarticles featuring quotesvideo clips and videos featuring supportive personal stories all on the subject of health and neurogenic orthostatic hypotension
Class 44
Medical information servicesproviding medical information regarding neurogenic orthostatic hypotension caused by Parkinson's diseasemultiple system atrophy and autonomic neuropathy
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/01/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/13/2025
PUBO
PUBLISHED FOR OPPOSITION
05/13/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/07/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/11/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/10/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/10/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/10/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/27/2025
GNRT
NON-FINAL ACTION E-MAILED
01/27/2025
CNRT
NON-FINAL ACTION WRITTEN
01/27/2025
DOCK
ASSIGNED TO EXAMINER
01/27/2025
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/26/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/26/2025
NWAP
NEW APPLICATION ENTERED
07/02/2024
Continuous trademark protection
Get notified about every new filing that threatens NORTHERA (DROXIDOPA) CAPSULES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.